Merck’s HPV Vaccine Sales Surge by 29% in Response to Global Demand
Merck & Co. Inc. has experienced a substantial increase in sales of their HPV vaccine, GARDASIL / GARDASIL 9, with a growth rate of 29%. … Read more
Merck & Co. Inc. has experienced a substantial increase in sales of their HPV vaccine, GARDASIL / GARDASIL 9, with a growth rate of 29%. … Read more